News

NU100 is a proprietary recombinant human interferon beta compound under development as a potential treatment for multiple sclerosis (MS) and will go into Phase III clinical trials in

The Phase II randomised clinical trial is designed to demonstrate the efficacy of adoptive cellular therapy for the pre-emptive treatment of cytomegalovirus (CMV) infections in patients who have

The ClinicalTrials.gov website is a registry of federally and privately supported clinical trials conducted in the US and around the world. The multi-centre, randomised, double-blind, placebo controlled Phase

Sodium thiopental is a sedative legally required for US lethal injections. In a statement, Novartis and Sandoz have said Sandoz has advised all its subsidiaries with locally approved

The trial is being conducted under the direction of James Cleary and George Cannon at the University of Wisconsin Carbone Cancer Center (UWCCC). ProCertus founder, chairman and chief

The study will assess tesetaxel as both first- and second-line chemotherapy. The study will evaluate two discrete populations: men with hormone/castrate-resistant prostate cancer, who have not previously received

STSI is an initiative of Scripps Health in collaboration with The Scripps Research Institute. The study establishes a link between coronary artery disease (CAD) and genetic susceptibility resulting

QLT091001 works as a replacement for 11-cis-retinal, a key biochemical component of the visual retinoid cycle, and is used to treat the inherited retinal degenerative diseases Leber Congenital

The cPMP replacement therapy is designed to treat patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare genetic disorder characterized severe brain damage and rapid death in